Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invyncible vs Medi-Weightloss

Invyncible
Graded #303

Lower grade

vs+8.599999999999994
Medi-Weightloss
Graded #126

Higher grade

The verdict

Medi-Weightloss takes it — 69.6/100 to 61/100.

Medi-Weightloss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medi-Weightloss is an established physician-supervised weight-loss brand with 130-plus locations nationwide plus telehealth.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvyncible +1
55
54
Dose & formulationMedi-Weightloss +1
64
65
Clinical oversightMedi-Weightloss +17
70
87
Labs & monitoringMedi-Weightloss +38
52
90
FulfillmentEven
65
65
Contract termsInvyncible +6
61
55
Invyncible · left barMedi-Weightloss · right bar

The numbers

MetricInvyncibleMedi-Weightloss
WeighScore61/10069.6/100
GradeCC
Scorecard rank#303#126
Semaglutide$192/mo (0.5 mg dose, compounded)$199/mo (promotional rate, brand-name)
Tirzepatide$210/mo (compounded)Not disclosed
Coverage40 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly
Medi-Weightloss

Graded #126 · C

Strengths

  • Both branded (Wegovy, Zepbound) and compounded semaglutide/tirzepatide
  • Established brand with 130+ physician-supervised locations nationwide
  • Telehealth plus in-person clinic options
  • Accepts insurance at many locations; HSA/FSA welcome
  • Includes body-composition analysis and personalized plans

Where it loses points

  • Ongoing medication pricing not transparently posted; varies by plan
  • $199 new-patient visit fee before medication costs
  • Frequent (often weekly) visits expected for some patients
  • Compounded products are not FDA-approved or evaluated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard